Search

everythinglearnresearchcommunity

for

Search:↓

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

The rash resolved after stopping ponatinib.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Early diagnosis and treatment are crucial for managing Berardinelli–Seip syndrome.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

SM04755 may be an effective topical treatment for psoriasis.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

The combination therapy was effective and well-tolerated, especially in young patients.

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tetracycline successfully treated a Labrador's skin calcification and hair loss.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.